BCG Report - Innovation for Impact: Unlocking the Potential of the UK’s Healthcare Ecosystem
NA
The Boston Consulting Group (BCG) report, "Innovation for Impact: Unlocking the Potential of the UK’s Healthcare Ecosystem," highlights the UK's strong foundations in healthcare innovation but notes that this potential is not consistently translated into patient impact and economic value.
The report identifies a significant untapped economic and societal opportunity, estimating that by 2030, the healthcare sector's contribution to GDP could be approximately £78 billion greater than current projections (a 76% increase), with further substantial benefits for the NHS and society.
Key Findings and Challenges
The report outlines the UK's strengths and the major barriers to innovation adoption and scaling:
Strong Foundations: The UK possesses world-class assets, including a prominent life sciences sector, leading academic institutions, rich health data, and the NHS as a unique national platform.
Untapped Potential: Despite these strengths, the translation of innovation into widespread patient benefit and economic growth is hampered.
Slow Adoption: The UK lags some European peers in the median time for new medicines to reach patients.
Economic Lag: The sector's economic contribution is lower than its potential.
Barriers to Innovation:
Workforce Capacity: There is a lack of capacity and capabilities for translational research and innovation within the NHS, often due to poorly defined career pathways, limited protected time for innovation, and a gap in digital/AI fluency.
Cultural and Process Hurdles: NHS staff often lack the support to test, adopt, and scale innovation, facing a risk-averse culture and disjointed policy and regulation.
Scaling Difficulty: While innovative solutions are frequently tested in the NHS, the biggest challenge is the successful scaling and diffusion of proven innovations from early-stage, site-specific adoption to national uptake, often limited by regional variability and disparate funding.
Long-Term Strategy: A lack of consistent, long-term strategy with collective accountability and sustained investment over a 3- to 10-year horizon prevents overcoming long-standing barriers.
Main Recommendations
The BCG report, often aligned with the goals of the NHS's own Innovation Ecosystem Programme, generally proposes a strategic and collaborative approach across the ecosystem to unlock this potential:
Prioritise and Align Innovation:
Focus Goals: Align the innovation ecosystem with the government's major health and economic goals, focusing on shifts like hospital to community, analogue to digital, and sickness to prevention (e.g., early detection, diagnosis, and personalised medicine).
Strategic Investment: Establish co-ordinated oversight and align innovation funding to fund fewer but larger pools of money to support scaling.
Make Innovation Core to NHS Business:
Workforce Integration: Embed innovation as a core part of NHS roles by developing clearer career pathways, providing protected time for innovation, and enhancing digital and AI literacy within the workforce.
Incentives and Monitoring: Develop incentives and monitor delivery using Key Performance Indicators (KPIs) for the testing and adoption of innovation to drive accountability.
Simplify and Strengthen Structures:
Streamline Governance: Simplify overcomplicated oversight structures to allow innovation programs to flourish at the local level while maintaining national consistency.
Data and IP: Strengthen data access and information governance to enable better collaboration across the NHS, academia, and industry, which is crucial for leveraging the UK's rich health data assets, especially for AI and genomic research.
Local Mobilisation: Encourage and support local systems to take the lead in co-ordination and decision-making for innovation adoption, promoting flexibility and rapid scaling from proven centres of excellence.